Melanoma Clinical Trials
Find clinical trials for melanoma. Search for melanoma clinical trials in different cities and states across the United States.
Iron & ImmunotherapyIntravenous Iron in Combination with Standard of Care Immunotherapy in Melanoma
Sponsor:
Indiana University
Location:
Code:
NCT06508827
Conditions
Anemia, Iron Deficiency
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Iron dextran 1000 mg IV
HLA TestingA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
Sponsor:
TScan Therapeutics, Inc.
Location:
Code:
NCT05812027
Conditions
Head and Neck Cancer
Cervical Cancer
Non Small Cell Lung Cancer
Melanoma
Ovarian Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tumor and HLA Profiling
Influenza VaccineIntralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
Sponsor:
Carlo Contreras
Location:
Code:
NCT04697576
Conditions
Clinical Stage I Cutaneous Melanoma AJCC V8
Clinical Stage IA Cutaneous Melanoma AJCC V8
Clinical Stage IB Cutaneous Melanoma AJCC V8
Clinical Stage II Cutaneous Melanoma AJCC V8
Clinical Stage IIA Cutaneous Melanoma AJCC V8
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ipilimumab
Nivolumab
Pembrolizumab
Quadrivalent Inactivated Influenza Vaccine
Resection
SX-682 with PembrolizumabSX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab
Sponsor:
Syntrix Biosystems, Inc.
Location:
Code:
NCT03161431
Conditions
Melanoma Stage III
Melanoma Stage IV
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SX-682
Pembrolizumab
AlpeliSib & PEmbroLizumabPhase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT06545682
Conditions
Myelodysplastic Syndrome(MDS)
Acute Myelogenous Leukemia (AML)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alpelisib + Pembrolizumab
AB248 & PembrolizumabA Study Evaluating AB248 Alone or in Combination with Pembrolizumab in Adult Patients with Solid Tumors
Sponsor:
Asher Biotherapeutics, Inc.
Location:
Code:
NCT05653882
Conditions
Solid Tumor
Non Small Cell Lung Cancer
Melanoma
Squamous Cell Carcinoma of Head and Neck
Renal Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
etakafusp alfa (AB248)
pembrolizumab
AvapritinibAvapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT04771520
Conditions
Anatomic Stage IV Breast Cancer AJCC v8
Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8
Locally Advanced Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Avapritinib
IK-595Study of IK-595 in RAS- or RAF-altered Advanced Tumors
Sponsor:
Ikena Oncology
Location:
Code:
NCT06270082
Conditions
Solid Tumor, Adult
Colorectal Cancer
Pancreatic Cancer
Malignant Melanoma
Ras (Kras or Nras) Gene Mutation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
IK-595
Radiotherapy & ImmunotherapyPRISM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal Melanoma
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT05546827
Conditions
Sinonasal Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Surgical resection
[225Ac]-FPI-1434A Phase 1/2 Study of [225Ac]-FPI-1434 Injection
Sponsor:
Fusion Pharmaceuticals Inc.
Location:
Code:
NCT03746431
Conditions
Advanced Solid Tumours
Endometrial Cancer
Cervical Cancer
Ovarian Cancer
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
[111In]-FPI-1547 Injection
[225Ac]-FPI-1434 Injection multi-dose
FPI-1175 Infusion
[225Ac]-FPI-1434 Injection single-dose